Common Stock, Shares, Outstanding of NeuBase Therapeutics, Inc. from 30 Sep 2010 to 30 Sep 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
NeuBase Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Sep 2010 to 30 Sep 2023.
  • NeuBase Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2023 was 3,729,206, a 89% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

NeuBase Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 3,729,206 -29,279,451 -89% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 1,878,146 -30,380,511 -94% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 33,810,356 +1,551,699 +4.8% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 1,657,768 -31,110,416 -95% 31 Dec 2022 10-Q 09 Nov 2023 2023 Q3
Q3 2022 33,008,657 +287,164 +0.88% 30 Sep 2022 10-QT 05 Jun 2023 2022 Q1
Q2 2022 32,258,657 -458,170 -1.4% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q3
Q1 2022 32,258,657 +9,078,633 +39% 31 Mar 2022 10-Q 12 May 2022 2022 Q2
Q4 2021 32,768,184 +9,590,593 +41% 31 Dec 2021 10-Q 11 Feb 2022 2022 Q1
Q3 2021 32,721,493 +9,567,409 +41% 30 Sep 2021 10-K 21 Dec 2022 2022 FY
Q2 2021 32,716,827 +9,596,631 +42% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q3
Q1 2021 23,180,024 +6,099,399 +36% 31 Mar 2021 10-Q 14 May 2021 2021 Q2
Q4 2020 23,177,591 +20,348,343 +719% 31 Dec 2020 10-Q 11 Feb 2021 2021 Q1
Q3 2020 23,154,084 +6,076,211 +36% 30 Sep 2020 10-K 23 Dec 2021 2021 FY
Q2 2020 23,120,196 +20,290,948 +717% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q3
Q1 2020 17,080,625 +14,251,377 +504% 31 Mar 2020 10-Q 14 May 2020 2020 Q2
Q4 2019 2,829,248 0 0% 31 Dec 2019 10-Q 26 Mar 2020 2020 Q1
Q3 2019 17,077,873 +11,350,783 +198% 30 Sep 2019 10-K 23 Dec 2020 2020 FY
Q2 2019 2,829,248 -53,637,180 -95% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q3
Q1 2019 2,829,248 -53,637,180 -95% 31 Mar 2019 10-Q 15 May 2019 2019 Q2
Q4 2018 2,829,248 -53,592,180 -95% 31 Dec 2018 10-Q 14 Feb 2019 2019 Q1
Q3 2018 5,727,090 -50,469,338 -90% 30 Sep 2018 10-K 10 Jan 2020 2019 FY
Q2 2018 56,466,428 +255,000 +0.45% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q3
Q1 2018 56,466,428 +20,505,032 +57% 31 Mar 2018 10-Q 15 May 2018 2018 Q2
Q4 2017 56,421,428 +20,460,032 +57% 31 Dec 2017 10-Q 14 Feb 2018 2018 Q1
Q3 2017 56,196,428 +24,120,032 +75% 30 Sep 2017 10-K 03 Jan 2019 2018 FY
Q2 2017 56,211,428 +24,706,225 +78% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q3
Q1 2017 35,961,396 +4,464,527 +14% 31 Mar 2017 10-Q 11 May 2017 2017 Q2
Q4 2016 35,961,396 +5,005,284 +16% 31 Dec 2016 10-Q 14 Feb 2017 2017 Q1
Q3 2016 32,076,396 +1,745,087 +5.8% 30 Sep 2016 10-K 15 Dec 2017 2017 FY
Q2 2016 31,505,203 +1,173,894 +3.9% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q3
Q1 2016 31,496,869 +1,538,277 +5.1% 31 Mar 2016 10-Q 10 May 2016 2016 Q2
Q4 2015 30,956,112 +5,689,970 +23% 31 Dec 2015 10-Q 09 Feb 2016 2016 Q1
Q3 2015 30,331,309 +5,077,119 +20% 30 Sep 2015 10-K 22 Dec 2016 2016 FY
Q2 2015 30,331,309 +5,468,664 +22% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q3
Q1 2015 29,958,592 +8,158,054 +37% 31 Mar 2015 10-Q 11 May 2015 2015 Q2
Q4 2014 25,266,142 +5,296,096 +27% 31 Dec 2014 10-Q 10 Feb 2015 2015 Q1
Q3 2014 25,254,190 +5,512,649 +28% 30 Sep 2014 10-K 14 Dec 2015 2015 FY
Q2 2014 24,862,645 30 Jun 2014 10-Q 18 Aug 2014 2014 Q3
Q1 2014 21,800,538 31 Mar 2014 10-Q 13 May 2014 2014 Q2
Q4 2013 19,970,046 31 Dec 2013 10-Q 14 Feb 2014 2014 Q1
Q3 2013 19,741,541 +3,988,645 +25% 30 Sep 2013 10-K 22 Dec 2014 2014 FY
Q3 2012 15,752,896 -23,949,684 -60% 30 Sep 2012 10-K 27 Dec 2013 2013 FY
Q1 2012 41,702,589 31 Mar 2012 10-Q 11 May 2012 2012 Q2
Q4 2011 41,535,922 31 Dec 2011 10-Q/A 14 Feb 2012 2012 Q1
Q3 2011 39,702,580 +4,250,000 +12% 30 Sep 2011 10-Q 11 May 2012 2012 Q2
Q2 2011 35,452,580 30 Jun 2011 10-Q 15 Aug 2011 2011 Q3
Q3 2010 35,452,580 30 Sep 2010 10-K/A 18 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.